-95.7%
SNDQ vs MRNA
+161.7%
-257.4%
-95.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -23.8% | -2.2% | -21.6% | -23.7% |
| 7D | -30.8% | +5.5% | -36.3% | -30.9% |
| 30D | -51.7% | +158.7% | -210.5% | -51.6% |
| 3M | -78.0% | +182.1% | -260.2% | -70.5% |
| All | -95.7% | +161.7% | -257.4% | -94.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · Available span rolling